Novel Intraoperative Molecular Test for Sentinel Lymph Node Metastases in Patients With Early-Stage Breast Cancer
Thomas B. Julian(Allegheny Health Network), Armando E. Giuliano(Cedars-Sinai Medical Center), Kenneth Deck(Allegheny General Hospital), Pat W. Whitworth(Southwestern Medical Center), Peter D. Beitsch(Dallas Surgical Group), Peter Blumencranz(Allegheny General Hospital), Donald A. Berry(Berry & Associates (United States)), Sukamal Saha(Allegheny General Hospital), Eleftherios P. Mamounas(Orlando Health), Rache M. Simmons(Cornell University), Douglas S. Reintgen(Allegheny General Hospital), Anees B. Chagpar(Yale University), Anne Rosenberg(Allegheny General Hospital), Scott Berry(Queen's University)
Cited by 87
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k